The FDA approved a wide range of therapies in 2024, including many new molecular entities and biological products.
Most notably, 226 of 521 FDA-approved medical devices, or approximately 43%, lacked published clinical validation data. A few ...
Most notably, 226 of 521 FDA-approved medical devices, or approximately 43%, lacked published clinical validation data. A few ...
The FDA just approved a new type of pain medication, and it's a non-opioid called suzetrigine that stops body pain at its ...
Among the wave of guidance documents issued by the U.S. Food and Drug Administration (“FDA” or the “Agency”) in the first week of 2025 were ...
The FDA warned the nation about the growing vulnerability of the medical device supply chain and its effects on public health, particularly among pediatric patients, in a Jan. 16 news release.
The FDA is ramping up efforts to address medical device shortages that are increasingly threatening patient care, particularly for pediatric and neonatal populations. In a Jan. 16 news release ...
What incentives are pediatric device developers missing? Drug developers are asked by the FDA whether their drug was also tested in the pediatric population, but the equivalent of that does not exist ...
Dr. Omer Awan is a practicing physician who covers public health. CARLSBAD ... for The Washington Post via Getty Images) The FDA recently approved Zepbound, a weekly injectable drug targeted ...